Andrew Daly
Overview
Explore the profile of Andrew Daly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
1043
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sergis V, Kelly D, Pramanick A, Britchfield G, Mason K, Daly A, et al.
Biofabrication
. 2025 Jan;
17(2.
PMID: 39808934
Despite significant advances in bioprinting technology, current hardware platforms lack the capability for process monitoring and quality control. This limitation hampers the translation of the technology into industrial GMP-compliant manufacturing...
2.
Hyman I, Van Sluys M, Foon J, Macgregor N, Anderson A, Patel T, et al.
PLoS One
. 2024 Dec;
19(12):e0314300.
PMID: 39680534
Norfolk Island, situated between Australia, New Zealand and New Caledonia, has a rich, narrowly endemic land snail fauna, which has suffered considerably from habitat loss and introduced predators. Eleven species...
3.
Randhawa B, Blosser N, Daly A, Storek J, Shaheen A, Jamani K
Cytotherapy
. 2024 Jul;
26(12):1514-1521.
PMID: 39046389
Background Aims: There are few descriptions of the epidemiology of chronic liver disease (CLD) after allogeneic hematopoietic stem cell transplantation (allo-HCT). Among those transplanted before 2000, viral hepatitis was the...
4.
Mori B, Daly A, Norman K, Wojkowski S
Physiother Can
. 2024 Mar;
76(1):111-120.
PMID: 38465297
Purpose: Clinical education and assessment of students' performance during clinical placements are key components of Canadian entry-to-practice physiotherapy curriculum and important in developing entry-level physiotherapy practitioners. The Canadian Physiotherapy Assessment...
5.
Maze D, Arcasoy M, Henrie R, Cerquozzi S, Kamble R, Al-Hadidi S, et al.
Bone Marrow Transplant
. 2024 Jan;
59(2):295.
PMID: 38279008
No abstract available.
6.
Maze D, Arcasoy M, Henrie R, Cerquozzi S, Kamble R, Al-Hadidi S, et al.
Bone Marrow Transplant
. 2023 Nov;
59(2):196-202.
PMID: 37938736
Allogeneic hematopoietic cell transplantation (HCT) is the only curative therapy for myelofibrosis (MF) and is recommended for patients with higher risk disease. However, there is a risk of early mortality,...
7.
Murthy H, Zhang M, Chen K, Ahmed S, Deotare U, Ganguly S, et al.
Blood Adv
. 2023 Oct;
7(22):7007-7016.
PMID: 37792849
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy with a poor prognosis and considered incurable with conventional chemotherapy. Small observational studies reported allogeneic hematopoietic cell transplantation (allo-HCT)...
8.
Puckrin R, Kwan A, Blosser N, Leyshon C, Duggan P, Daly A, et al.
Cytotherapy
. 2023 Jun;
25(10):1101-1106.
PMID: 37306643
Background Aims: Although calcineurin inhibitors (CNIs) have a well-established role in the prevention of graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT), their use can be limited by significant...
9.
Tripathi G, Khanolkar R, Faridi R, Kalra A, Dharmani-Khan P, Shabani-Rad M, et al.
Int J Mol Sci
. 2022 Dec;
23(24).
PMID: 36555525
The persistence of graft-versus-host disease (GVHD) as the principal complication of allogeneic hematopoietic cell transplantation (HCT) demonstrates that HLA matching alone is insufficient to prevent alloreactivity. We performed molecular and...
10.
Maier S, Berg T, Berrigan S, Bramson J, Bredeson C, Cantin G, et al.
Curr Oncol
. 2022 Dec;
29(12):9970-10017.
PMID: 36547197
On behalf of Cell Therapy Transplant Canada (CTTC), we are pleased to present the Abstracts of the CTTC 2022 Annual Conference. The conference was held in-person 15-18 June 2022, in...